Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Patient-reported Satisfaction and Regret Following Focal Therapy for Prostate Cancer: A Prospective Multicenter Evaluation.
Ghoreifi A, Kaneko M, Peretsman S, Iwata A, Brooks J, Shakir A, Sugano D, Cai J, Cacciamani G, Park D, Lebastchi AH, Ukimura O, Bahn D, Gill I, Abreu AL. Ghoreifi A, et al. Among authors: bahn d. Eur Urol Open Sci. 2023 Feb 18;50:10-16. doi: 10.1016/j.euros.2023.02.003. eCollection 2023 Apr. Eur Urol Open Sci. 2023. PMID: 37101771 Free PMC article.
A phase I prospective, non-randomized trial of autologous dendritic cell-based cryoimmunotherapy in patients with metastatic castration-resistant prostate cancer.
Thomsen LCV, Honoré A, Reisæter LAR, Almås B, Børretzen A, Helle SI, Førde K, Kristoffersen EK, Kaada SH, Melve GK, Haslerud TM, Biermann M, Bigalke I, Kvalheim G, Azeem W, Olsen JR, Gabriel B, Knappskog S, Halvorsen OJ, Akslen LA, Bahn D, Pantel K, Riethdorf S, Ragde H, Gjertsen BT, Øyan AM, Kalland KH, Beisland C. Thomsen LCV, et al. Among authors: bahn d. Cancer Immunol Immunother. 2023 Jul;72(7):2357-2373. doi: 10.1007/s00262-023-03421-7. Epub 2023 Mar 20. Cancer Immunol Immunother. 2023. PMID: 36939854 Free PMC article. Clinical Trial.
Five-alpha reductase inhibitors in men undergoing active surveillance for prostate cancer: impact on treatment and reclassification after 6 years follow-up.
Ashrafi AN, Shin T, Marien A, Clifford T, Shoji S, Iwata T, Iwata A, Oishi M, Chopra S, Cai J, Ukimura O, Bahn D, Gill IS, Abreu AL. Ashrafi AN, et al. Among authors: bahn d. World J Urol. 2021 Sep;39(9):3295-3307. doi: 10.1007/s00345-021-03644-2. Epub 2021 Mar 8. World J Urol. 2021. PMID: 33683411
Reply by Authors.
Oishi M, Gill IS, Tafuri A, Shakir A, Cacciamani GE, Iwata T, Iwata A, Ashrafi A, Park D, Cai J, Desai M, Ukimura O, Bahn DK, Abreu AL. Oishi M, et al. Among authors: bahn dk. J Urol. 2020 Jul;204(1):158-159. doi: 10.1097/JU.0000000000001009. Epub 2020 Mar 6. J Urol. 2020. PMID: 32149568 No abstract available.
Reply by Authors.
Oishi M, Gill IS, Tafuri A, Shakir A, Cacciamani GE, Iwata T, Iwata A, Ashrafi A, Park D, Cai J, Desai M, Ukimura O, Bahn DK, Abreu AL. Oishi M, et al. Among authors: bahn dk. J Urol. 2019 Dec;202(6):1198. doi: 10.1097/01.JU.0000582672.51608.a4. Epub 2019 Sep 16. J Urol. 2019. PMID: 31524574 No abstract available.
51 results